Clinical presentation and outcomes of chronic dialysis patients with COVID-19: A single center experience from Greece

Table 1 Comparison of demographics and baseline characteristics of patients grouped by outcome

	Total patients, n (%)	Survivors, n (%)	Non-survivors, n (%)	P value	Non-progressors, n (%)	Progressors, n (%)	P value
Characteristic	32 (100)	27 (84.4)	5 (15.6)		19 (59.3)	13 (40.6)
Male	17 (53.1)	16 (59.3)	1 (20)	NS	9 (47.4)	8 (61.5)	NS
Female	15 (46.9)	11 (40.7)	4 (80)		10 (52.6)	5 (38.5)
1Age	75.5 (58.5-82)	75 (56-82)	76 (75-80)	NS	70 (53-82)	78 (75-82)	NS
1Frailty index	3 (2-5)	3 (2-5)	7 (3-8)	< 0.05	3 (2-5)	3 (2-5)	NS
CT (%)				< 0.01			NS
0-10%	24 (77.4)	23 (88.5)	1 (20)		16 (84.2)	8 (66.7)
> 10%	7 (22.6)	3 (11.5)	4 (80)		3 (15.8)	4 (33.3)
WHΟ				0.05			NS
0	16 (50)	15 (55.6)	1 (20)		11 (57.8)	5 (38.5)
1	13 (40.6)	11 (40.7)	2 (40)		8 (42.1)	5 (38.5)
2-3	3 (9.4)	1 (3.7)	2 (40)		0 (0)	3 (23)
Diabetes	10 (31.3)	7 (25.9)	3 (60)	NS	7 (36.8)	3 (23.1)	NS
Hypertension	20 (62.5)	18 (66.7)	2 (40)	NS	11 (57.8)	9 (69.2)	NS
1Number of comorbidities	3 (2-3.5)	3 (2-4)	3 (2-3)	NS	3 (1-4)	3 (2-3)	NS
Symptoms				NS			NS
Fever	13 (65)	10 (62.5)	3 (75)		8 (80)	5 (50)
Respiratory	6 (30)	5 (31.2)	1 (25)		1 (10)	5 (50)
Diarrhea	1 (5)	1 (6.3)	0 (0)		1 (10)	0 (0)
COVID diagnosis				NS			NS
With symptoms	20 (62.5)	16 (59.3)	4 (80)		10 (52.6)	10 (76.9)
Screening	12 (37.5)	11 (40.7)	1 (20)		9 (47.4)	3 (23.1)

¹Median (interquartile range).

WHO severity score: 0: Mild disease, 1: Moderate disease, 2: Severe disease.

CT: Computed tomography; NS: Non-significant; COVID: Coronavirus disease.